Health ❯ Preventive Medicine
Risk Factors Research Studies Risk Assessment Risk Management Screening Mortality Risk
By switching off ANGPTL3 in the liver, CTX310 produced rapid lipid reductions in 15 adults, with only mild short-term reactions reported.
